Crossmark

HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer’s-associated markers

Crossref DOI link: https://doi.org/10.1007/s11011-024-01515-4

Published Online: 2024-12-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salari, Adel

Roghani, Mehrdad

Khalili, Mohsen
Funding

Funding for this research was provided by:

Shahed University (503338)
License Information

Text and Data Mining valid from 2024-12-20

Version of Record valid from 2024-12-20
More Information

Article History

Received: 22 May 2024

Accepted: 18 December 2024

First Online: 20 December 2024

Declarations

:

: All experimental procedures of this study were conducted under ethics committee supervision of Shahed University (# IR.SHAHED.REC.1401.137) that was in accordance to NIH guidelines for the care and use of laboratory animals. All efforts were made to minimize number of animals and to lower their sufferings.

: All authors have read the manuscript and approved its submission.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below